Capital Research Global Investors 13D and 13G filings for Haemonetics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-04 4:24 pm Sale |
2025-03-31 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 1,577,323 3.100% |
-2,865,330 (-64.50%) |
Filing |
| 2024-11-12 12:54 pm Sale |
2024-11-07 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 4,442,653 8.700% |
-2,080,915 (-31.90%) |
Filing |
| 2024-02-09 5:49 pm Purchase |
2024-02-07 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 6,523,568 12.900% |
567,504 (+9.53%) |
Filing |
| 2023-02-13 3:32 pm Purchase |
2023-02-14 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 5,956,064 11.800% |
504,058 (+9.25%) |
Filing |
| 2022-04-08 11:19 am Purchase |
2022-04-11 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 5,452,006 10.700% |
3,402,873 (+166.06%) |
Filing |
| 2022-02-11 12:22 pm Sale |
2022-02-14 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 2,049,133 4.000% |
-726,503 (-26.17%) |
Filing |
| 2021-06-10 11:46 am Sale |
2021-06-10 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 2,775,636 5.400% |
-2,862,099 (-50.77%) |
Filing |
| 2021-02-16 3:11 pm Purchase |
2021-02-16 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 5,637,735 11.100% |
437,670 (+8.42%) |
Filing |
| 2020-11-10 12:33 pm Purchase |
2020-11-10 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 5,200,065 10.200% |
2,505,265 (+92.97%) |
Filing |